• Explore /
  • Poster
  • / Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

Abstract Poster

Authors

null

Jennifer Rachel Eads

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

Jennifer Rachel Eads , Smitha S. Krishnamurthi , Joel N. Saltzman , Neal J. Meropol , Joseph A. Bokar , Joseph Gibbons , Henry B. Koon , Neelesh Sharma , Panayiotis Savvides , John Pink , Yan Xu , Jan Hendrik Beumer , Pingfu Fu , Kristi Beatty , Donna Kane , Mary Beth Rodal , Julianne Czalkiewicz , John Riendeau , Stanton L. Gerson , Afshin Dowlati

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

DNA Repair and Apoptosis

Clinical Trial Registration Number

NCT00892385

Citation

J Clin Oncol 33, 2015 (suppl; abstr 2558)

DOI

10.1200/jco.2015.33.15_suppl.2558

Abstract #

2558

Poster Bd #

274

Abstract Disclosures

Similar Posters

First Author: Álvaro Lassaletta

First Author: Jennifer Foster

First Author: Nataliya Volodymyrivna Uboha

Poster

2019 ASCO Annual Meeting

A phase I study of a novel MDM2 antagonist APG-115 in patients with advanced solid tumors.

A phase I study of a novel MDM2 antagonist APG-115 in patients with advanced solid tumors.

First Author: Drew W. Rasco